FDA Application
-
NDC Search Results on Active Ingredient: codeine
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE | 50383-804-16 | Akorn | ANDA040151 | HUMAN PRESCRIPTION DRUG | ANDA |
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE | 17856-0605-1 | ATLANTIC BIOLOGICALS CORP. | ANDA088875 | HUMAN PRESCRIPTION DRUG | ANDA |
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE | 12634-909-16 | Apotheca Inc | ANDA040151 | HUMAN PRESCRIPTION DRUG | ANDA |
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE | 50383-805-16 | Akorn | ANDA040674 | HUMAN PRESCRIPTION DRUG | ANDA |
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE | 55045-1266-8 | Dispensing Solutions, Inc. | ANDA040660 | HUMAN PRESCRIPTION DRUG | ANDA |
PROMETHAZINE HYDROCHLORIDE; CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE | 50383-805-04 | Akorn | ANDA040674 | HUMAN PRESCRIPTION DRUG | ANDA |
PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE | 60575-515-16 | Respa Pharmaceuticals, Inc | part341 | HUMAN OTC DRUG | OTC monograph final |
PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE; GUAIFENESIN | 54859-520-16 | Llorens Pharmaceutical International Division | part341 | HUMAN OTC DRUG | OTC monograph final |
PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE; GUAIFENESIN | 43378-121-04 | codaDOSE Incorporated | part341 | HUMAN OTC DRUG | OTC monograph final |
PSEUDOEPHEDRINE HYDROCHLORIDE; CODEINE PHOSPHATE; GUAIFENESIN | 43378-124-08 | codaDOSE Incorporated | part341 | HUMAN OTC DRUG | OTC monograph final |
PSEUDOEPHEDRINE; GUAIFENESIN; CODEINE PHOSPHATE | 43378-126-08 | codaDOSE Incorporated | part341 | HUMAN OTC DRUG | OTC monograph final |
PYRILAMINE MALEATE; CODEINE PHOSPHATE | 66594-333-01 | Pro-Pharma LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
PYRILAMINE MALEATE; CODEINE PHOSPHATE | 66594-333-16 | Pro-Pharma LLC | part341 | HUMAN OTC DRUG | OTC monograph final |
1-30 | 31-60 | 61-90 | 91-120 | 121-150 | 151-180 | 181-210 | 211-240 | 241-270 | 271-300 |
301-330 | 331-360 | 361-390 | 391-420 | 421-450 | 451-480 | 481-510 | 511-540 | 541-570 | 571-600 |
601-630 | 631-660 | 661-690 | 691-720 | 721-750 | 751-763 |
-